WASHINGTON - The head of the U.S. effort to produce a coronavirus vaccine says the first immunizations could happen on Dec. 12.
A Food and Drug Administration advisory committee is set to meet Dec. 10 to discuss Pfizer Inc.’s request for an emergency use authorization for its developing COVID-19 vaccine.
Pfizer and its German partner BioNTech recently announced that the vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.
Dr. Moncef Slaoui, head of the Operation Warp Speed, the coronavirus vaccine program, says plans are to ship vaccines to states within 24 hours of expected FDA approval.
Slaoui told CNN he expects vaccinations would begin on the second day after approval, Dec. 12
HERE’S WHAT YOU NEED TO KNOW ABOUT THE VIRUS OUTBREAK:
— FDA allows emergency use of antibody drug thatTrump received
— British Prime Minister Boris Johnson plans to end an England-wide virus lockdown as scheduled on Dec. 2 and will return to regional restrictions as coronavirus infections stabilize.
— Russia’s health system under strain as virus surges back
— Many ignore virus precautions at funeral of Serbian Patriarch Irinej who died after contracting the coronavirus.
—Madrid’s emblematic Rastro flea market has reopened Sunday after a contentious eight-month closure because of the pandemic.
— Black clergy join with United Way to fight COVID-19′s outsize toll on African-Americans.